Jessen F - Search Results

1

Neurokinin3 receptor as a target to predict and improve learning and memory in the aged organism.

de Souza Silva MA, Lenz B, Rotter A, Biermann T, Peters O, Ramirez A, Jessen F, Maier W, Hüll M, Schröder J, Frölich L, Teipel S, Gruber O, Kornhuber J, Huston JP, Müller CP, Schäble S. de Souza Silva MA, et al. Among authors: jessen f. Proc Natl Acad Sci U S A. 2013 Sep 10;110(37):15097-102. doi: 10.1073/pnas.1306884110. Epub 2013 Aug 27. Proc Natl Acad Sci U S A. 2013. PMID: 23983264 Free PMC article.

2

A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease.

Papassotiropoulos A, Bagli M, Jessen F, Bayer TA, Maier W, Rao ML, Heun R. Papassotiropoulos A, et al. Among authors: jessen f. Ann Neurol. 1999 May;45(5):666-8. doi: 10.1002/1531-8249(199905)45:5<666::aid-ana18>3.0.co;2-3. Ann Neurol. 1999. PMID: 10319892

3

Association of an interleukin-1beta gene polymorphism at position -511 with Alzheimer's disease.

Ehl C, Kölsch H, Ptok U, Jessen F, Schmitz S, Frahnert C, Schlösser R, Rao ML, Maier W, Heun R. Ehl C, et al. Among authors: jessen f. Int J Mol Med. 2003 Feb;11(2):235-8. Int J Mol Med. 2003. PMID: 12525884

4

Contribution of apolipoprotein E and cathepsin D genotypes to the familial aggregation of Alzheimer's disease.

Heun R, Ptok U, Kölsch H, Maier W, Jessen F. Heun R, et al. Among authors: jessen f. Dement Geriatr Cogn Disord. 2004;18(2):151-8. doi: 10.1159/000079195. Epub 2004 Jun 18. Dement Geriatr Cogn Disord. 2004. PMID: 15211070

5

Polymorphism in neuropeptide Y influences CSF cholesterol levels but is no major risk factor of Alzheimer's disease.

Kölsch H, Lütjohann D, Jessen F, Urbach H, von Bergmann K, Maier W, Heun R. Kölsch H, et al. Among authors: jessen f. J Neural Transm (Vienna). 2006 Feb;113(2):231-8. doi: 10.1007/s00702-005-0319-z. Epub 2005 Jun 15. J Neural Transm (Vienna). 2006. PMID: 15959845

6

APOA1 polymorphism influences risk for early-onset nonfamiliar AD.

Vollbach H, Heun R, Morris CM, Edwardson JA, McKeith IG, Jessen F, Schulz A, Maier W, Kölsch H. Vollbach H, et al. Among authors: jessen f. Ann Neurol. 2005 Sep;58(3):436-41. doi: 10.1002/ana.20593. Ann Neurol. 2005. PMID: 16130094

7

Volume reduction of the entorhinal cortex in subjective memory impairment.

Jessen F, Feyen L, Freymann K, Tepest R, Maier W, Heun R, Schild HH, Scheef L. Jessen F, et al. Neurobiol Aging. 2006 Dec;27(12):1751-6. doi: 10.1016/j.neurobiolaging.2005.10.010. Epub 2005 Nov 23. Neurobiol Aging. 2006. PMID: 16309795

8

Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction.

Quednow BB, Jessen F, Kuhn KU, Maier W, Daum I, Wagner M. Quednow BB, et al. Among authors: jessen f. J Psychopharmacol. 2006 May;20(3):373-84. doi: 10.1177/0269881106061200. J Psychopharmacol. 2006. PMID: 16574711

9

PPARD haplotype influences cholesterol metabolism but is no risk factor of Alzheimer's disease.

Holzapfel J, Heun R, Lütjohann D, Jessen F, Maier W, Kölsch H. Holzapfel J, et al. Among authors: jessen f. Neurosci Lett. 2006 Nov 6;408(1):57-61. doi: 10.1016/j.neulet.2006.08.029. Epub 2006 Sep 18. Neurosci Lett. 2006. PMID: 16979821

10

[A contribution to the current discussion on anti-dementia drugs in Germany].

Jessen F, Maier W. Jessen F, et al. Nervenarzt. 2007 May;78(5):491-2, 494, 496-7. doi: 10.1007/s00115-006-2204-x. Nervenarzt. 2007. PMID: 17106726 Review. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

629 results

Search Page